Kaken Pharmaceutical (4521.TSE) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
42.24
52.23
62.21
72.2

Details

Expected EPS
N/A
Actual EPS
42.24020851200001
Surprise EPS
42.24
Surprise Percent
+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 42.24020851200001 per share for Q3 2024.

0 Comments

Share your thoughts